This content is restricted to site members. If you are an existing user, please log in. New users may register below.
Novartis receives FDA approval for Cosentyx® label update to include moderate to severe scalp psoriasis
February 22, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on efforts to safeguard women’s health from deceptive health claims and significant risks related to devices marketed for use in medical procedures for “vaginal rejuvenation”
September 7, 2018